SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 134 filers reported holding SCICLONE PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,238,000 | -32.6% | 110,500 | -33.9% | 0.08% | -30.0% |
| Q2 2017 | $1,838,000 | -21.9% | 167,113 | -30.4% | 0.12% | -4.8% |
| Q1 2017 | $2,352,000 | -5.8% | 240,013 | +3.8% | 0.13% | -15.4% |
| Q4 2016 | $2,497,000 | +20.9% | 231,214 | +14.7% | 0.15% | +34.2% |
| Q3 2016 | $2,066,000 | -24.4% | 201,513 | -3.6% | 0.11% | -26.5% |
| Q2 2016 | $2,731,000 | -20.4% | 209,113 | -33.0% | 0.15% | -31.1% |
| Q1 2016 | $3,433,000 | +14.8% | 312,115 | -4.0% | 0.22% | +50.0% |
| Q4 2015 | $2,991,000 | +59.1% | 325,115 | +20.0% | 0.15% | +58.7% |
| Q3 2015 | $1,880,000 | -52.8% | 270,888 | -33.3% | 0.09% | -39.9% |
| Q2 2015 | $3,987,000 | +30.1% | 406,002 | +17.4% | 0.15% | +25.4% |
| Q1 2015 | $3,064,000 | +116.8% | 345,833 | +114.4% | 0.12% | +23.2% |
| Q4 2014 | $1,413,000 | +71.1% | 161,289 | +34.5% | 0.10% | +130.2% |
| Q3 2014 | $826,000 | +20.9% | 119,926 | -7.7% | 0.04% | +38.7% |
| Q2 2014 | $683,000 | +28.9% | 129,907 | +11.5% | 0.03% | -18.4% |
| Q1 2014 | $530,000 | -14.2% | 116,490 | -5.1% | 0.04% | -22.4% |
| Q4 2013 | $618,000 | +10.6% | 122,694 | +11.2% | 0.05% | +11.4% |
| Q3 2013 | $559,000 | +146.3% | 110,342 | +140.9% | 0.04% | +63.0% |
| Q2 2013 | $227,000 | – | 45,813 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|